Financials

  • Market Capitalization 63.83 M
  • Employee 21
  • Founded 2015
  • CEO N/A
  • Website www.inmunebio.com
  • Headquarter Nevada, United States
  • FIGI BBG00LW94L98
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.59
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4163
HYFT
MindWalk Holdings Corp. - Common Stock
1.37 USD-1.44%-0.72%+6.20%-32.18%64.00 M USD
4165
BOLD
Boundless Bio, Inc. - Common Stock
2.81 USD-0.71%-5.07%+12.85%+142.24%63.92 M USD
4174
SER
Serina Therapeutics, Inc. Common Stock
2.46 USD0.00%-6.11%+22.39%+47.75%62.49 M USD
4187
HRTX
Heron Therapeutics, Inc. - Common Stock
0.32 USD-3.03%-5.88%-36.00%-76.30%60.75 M USD

Notizie